Grifols SA
NASDAQ:GRFS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Grifols SA
NASDAQ:GRFS
|
ES |
|
Adicet Bio Inc
NASDAQ:ACET
|
US |
|
Foot Locker Inc
NYSE:FL
|
US |
|
Larimar Therapeutics Inc
NASDAQ:LRMR
|
US |
|
A
|
Agilent Technologies Inc
XMUN:AG8
|
US |
|
C
|
Caravelle International Group
NASDAQ:CACO
|
SG |
|
Skyworks Solutions Inc
NASDAQ:SWKS
|
US |
|
Reliance Power Ltd
NSE:RPOWER
|
IN |
|
Shiseido Co Ltd
TSE:4911
|
JP |
|
Blackstone Inc
NYSE:BX
|
US |
|
Bath & Body Works Inc
NYSE:BBWI
|
US |
Wall St Price Targets
GRFS Price Targets Summary
Grifols SA
According to Wall Street analysts, the average 1-year price target for GRFS is 13.05 USD with a low forecast of 7.9 USD and a high forecast of 19.34 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GRFS's stock price target?
Price Target
13.05
USD
According to Wall Street analysts, the average 1-year price target for GRFS is 13.05 USD with a low forecast of 7.9 USD and a high forecast of 19.34 USD.
What is the Revenue forecast for Grifols SA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Grifols SA?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 8 years is 10%.
What is the Net Income forecast for Grifols SA?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 5 years is 24%.
